Compare CVAC & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVAC | PNTG |
|---|---|---|
| Founded | 2000 | 2019 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2020 | N/A |
| Metric | CVAC | PNTG |
|---|---|---|
| Price | $4.66 | $28.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $6.83 | ★ $35.33 |
| AVG Volume (30 Days) | ★ 1.3M | 205.9K |
| Earning Date | 11-24-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.02 | 10.47 |
| EPS | ★ 0.94 | 0.75 |
| Revenue | $83,000,117.00 | ★ $847,274,000.00 |
| Revenue This Year | N/A | $36.42 |
| Revenue Next Year | $23.71 | $23.99 |
| P/E Ratio | ★ $4.98 | $38.03 |
| Revenue Growth | N/A | ★ 29.89 |
| 52 Week Low | $2.48 | $21.18 |
| 52 Week High | $5.72 | $30.46 |
| Indicator | CVAC | PNTG |
|---|---|---|
| Relative Strength Index (RSI) | 47.92 | 55.21 |
| Support Level | $4.26 | $27.53 |
| Resistance Level | $4.68 | $29.91 |
| Average True Range (ATR) | 0.17 | 0.69 |
| MACD | 0.04 | -0.21 |
| Stochastic Oscillator | 62.56 | 57.44 |
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.